Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Patents
  • Published:

Intellectual property policies in early-phase research in public–private partnerships

Nature Biotechnology volume 34, pages 504–510 (2016)Cite this article

Subjects

Knowledge-sharing strategies differ depending on the nature of the research objectives of public–private partnerships, but information about such strategies is often vague.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: IP frameworks as defined in the policies of the selected PPPs.
Figure 2: Link between IP frameworks as defined in the IP policies of the PPPs analyzed, the information provided in the IP policies, project focus and project deliverables.

References

  1. Woodcock, J. Clin. Pharmacol. Ther. 87, 521–523 (2010).

    Article  CAS  Google Scholar 

  2. Sidders, B. et al. Nat. Rev. Drug Discov. 13, 83–84 (2014).

    Article  CAS  Google Scholar 

  3. Stevens, H., Van Overwalle, G., Van Looy, B. & Huys, I. Biotechnol. Law Rep. 32, 131–139 (2013).

    Article  Google Scholar 

  4. Bubela, T., FitzGerald, G.A. & Gold, E.R. Sci. Transl. Med. 4, 122cm3 (2012).

    Article  Google Scholar 

  5. Dolgin, E. Nat. Med. 20, 564–565 (2014).

    Article  CAS  Google Scholar 

  6. Bubela, T. et al. J. Law Info. Sci. 20, 98–121 (2012).

    Google Scholar 

  7. Ziemba, E. Update on 2004 Background Paper 8.1 Public Private Partnerships (World Health Organization, 2013).

    Google Scholar 

  8. Chon, M. PPPs in Global IP (Public-Private Partnerships in Global Intellectual Property). Jean Monnet Working Paper 13/12 (New York University School of Law, 2012).

    Google Scholar 

  9. Kaplan, W. et al. Priority Medicines for Europe and the World 2013 Update (World Health Organization, 2013).

    Google Scholar 

  10. Mahoney, R.T., Krattiger, A., Clemens, J.D. & Curtiss, R. III. Vaccine 25, 4003–4011 (2007).

    Article  Google Scholar 

  11. Leten, B., Vanhaverbeke, W., Roijakkers, N., Clerix, A. & Van Helleputt, J. Calif. Manage. Rev. 55, 51–64 (2013).

    Article  Google Scholar 

  12. Bereuter, T.L., Jerolitsch, D. & Heimerl, P.g. Les Nouvelles http://www.lesi.org/les-nouvelles/les-nouvelles-online/september-2011/2011/08/29/ipr-codes-and-guidelines-in-europe-facilitating-collaboration-of-publicly-funded-research-organizations-(pros)-with-businesses-part-1 (2011).

  13. Chesbrough, H. Open Innovation: the New Imperative for Creating and Profiting from Technology (Harvard Business School Press, 2003).

    Google Scholar 

  14. Chesbrough, H. Open Business Models: How to Thrive in the New Innovation Landscape (Harvard Business School Press, 2006).

    Google Scholar 

  15. Van Overwalle, G. in Kritika-Essays on Intellectual Property, Vol. 1 (eds. Drahos, P. et al.) Inventing inclusive patents. From old to new open innovation (Edward Elgar, 2015).

    Google Scholar 

  16. Gold, E.R. & Nicol, D. in Comparative Issues in the Governance of Research Biobanks—Property, Privacy, Intellectual Property, and the Role of Technology (eds. Pascuzzi, G., Izzo, U. & Macilotti, M.) 191–208 (Springer, 2013).

    Google Scholar 

  17. Van Overwalle, G. WIPO J. 4, 139–156 (2013).

    Google Scholar 

  18. Feldman, R. & Nelson, K. Northwestern J. Technol. Intel. Prop. (2008). http://ssrn.com/abstract=1127571

  19. Murray, F., Aghion, P., Dewatripont, M., Kolev, J. & Stern, S. Of Mice and Academics: Examining the Effect Of Openness On Innovation. Working Paper 14819. (National Bureau of Economic Research, 2009).

    Book  Google Scholar 

  20. Feldman, R. Minn. J. Law Sci. Technol. 6, 117–167 (2004).

    Google Scholar 

  21. http://www.thesgc.org/blog/why-put-science-in-the-public-domain

  22. Stevens, H. et al. Biotechnol. Law Rep. 34, 153–165 (2015).

    Article  Google Scholar 

  23. Collaborative Computational Technologies for Biomedical Research (eds. Elkins, S. et al.) (Wiley, 2011).

Download references

Acknowledgements

The authors gratefully acknowledge the Brocher Foundation for hosting H.S. as a visiting researcher (July 2013 and April 2015). The authors also wish to thank K. Debackere, F. Luyten, A. Van Aerschot, D. Lacombe, E. Tambuyzer, A. Krattiger and R. Wilders for their comments.

Author information

Authors and Affiliations

  1. Department of Pharmaceutical and Pharmacological Sciences, Research Centre for Clinical Pharmacology and Pharmacotherapy, University of Leuven, Leuven, Belgium

    Hilde Stevens & Isabelle Huys

  2. Centre for IT & IP Law (CiTiP), University of Leuven, Leuven, Belgium

    Hilde Stevens, Geertrui Van Overwalle & Isabelle Huys

  3. Institute for Interdisciplinary Innovation in healthcare (Ih), Université libre de Bruxelles, Brussels, Belgium

    Hilde Stevens

  4. Visiting professor, Tilburg University, Tilburg, the Netherlands

    Geertrui Van Overwalle

  5. Department of Managerial Economics, Strategy and Innovation, University of Leuven, Leuven, Belgium

    Bart Van Looy

  6. Centre for Research and Development Monitoring, Leuven, Belgium

    Bart Van Looy

Authors
  1. Hilde Stevens
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Geertrui Van Overwalle
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bart Van Looy
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Isabelle Huys
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hilde Stevens.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Text and Figures

Supplementary Results (PDF 197 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Stevens, H., Van Overwalle, G., Van Looy, B. et al. Intellectual property policies in early-phase research in public–private partnerships. Nat Biotechnol 34, 504–510 (2016). https://doi.org/10.1038/nbt.3562

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.3562

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research